CG Oncology bladder cancer immunotherapy cut recurrence risk by 68%
CG Oncology says its bladder cancer immunotherapy reduced the risk of tumor recurrence by 68%, results that may change how physicians treat certain patients, STAT reports. Which…
1 post ·